Jj. Gangemi et al., Retrograde perfusion with a sodium channel antagonist provides ischemic spinal cord protection, ANN THORAC, 69(6), 2000, pp. 1744-1748
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems","Medical Research Diagnosis & Treatment
Background. Neuronal voltage-dependent sodium channel antagonists have been
shown to provide neuroprotection in focal and global cerebral ischemic mod
els. We hypothesized that retrograde spinal cord venous perfusion with phen
ytoin, a neuronal voltage-dependent sodium channel antagonist, would provid
e protection during prolonged spinal cord ischemia.
Methods. In a rabbit model, spinal cord ischemia was induced for 45 minutes
. Six groups of animals were studied. Controls (group I, n = 8) received no
intervention during aortic cross-clamping. Group II (n = 8) received syste
mic phenytoin (100 mg). Group III (n = 4) received systemic phenytoin (200
mg). Group IV (n = 8) received retrograde infusion of room temperature sali
ne (22 degrees C) only. Group V (n = 8) and group VI (n = 9) received retro
grade infusion of 50 mg and 100 mg of phenytoin, respectively, (infusion ra
te: 0.8 mL . kg(-1) . min(-1) during the ischemic period). Mean arterial bl
ood pressure was monitored continuously. Animals were allowed to recover fo
r 24 hours before assessment of neurologic function using the Tarlov scale.
Results. Tarlov scores (0 = complete paraplegia, 1 slight lower limb moveme
nt, 2 = sits with assistance, 3 = sits alone, 4 = weak hop, 5 = normal hop)
were as follows (mean +/- SEM): group I, 0.50 +/- 0.50; group II, 0.25 +/-
0.46; group N, 1.63 +/- 0.56; group V, 4.13 +/- 0.23; and group VI, 4.22 /- 0.22 (p < 0.0001 V, VI Versus I, II, IV by analysis of variance). No dif
ferences in mean arterial blood pressure were observed. All animals in grou
p III became profoundly hypotensive and died before the conclusion of the 4
5-minute ischemic time.
Conclusions. Retrograde venous perfusion of the spinal cord with phenytoin,
a voltage-sensitive sodium channel blocker, is safe and provides significa
nt protection during prolonged spinal cord ischemia. (C) 2000 by The Societ
y of Thoracic Surgeons.